A novel anti-PD-L1/IL-8 bispecific antibody BP2402 enhances antitumor immunity and modulates inflammatory signaling in triple-negative breast cancer mice model.
新型抗PD-L1/IL-8双特异性抗体BP2402可增强三阴性乳腺癌小鼠模型的抗肿瘤免疫力并调节炎症信号传导。
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-07105-x
Song Liying, Tang Sumin, Pi Xuelei, Yan Yuanyuan, Hu Chenxi, Liu Liang, Chen Hongna, Zhang Yating, Liu Shishi, Yu Dan, Yin Chengkai, Liu Tianyan, Li Xu, Li Deshan, Wang Zhenzhong, Zhu Wei, Hui Kaiyuan, Liu Zhihang, Jiang Xiaodong
